Results 291 to 300 of about 2,642,809 (351)

Chronic gastritis rat model and role of inducing factors

, 2004
Zun Xiang
openalex   +1 more source

CHRONIC HYPERTROPHIC ANTRUM GASTRITIS

Annals of Surgery, 1945
openaire   +3 more sources

Pediatric Brain Tumors in Western Kenya: Patient Outcomes and Healthcare Providers’ Perspectives

Pediatric Blood &Cancer, Volume 72, Issue 4, April 2025.
ABSTRACT Background Pediatric brain tumors are understudied compared to other pediatric malignancies in low‐ and middle‐income countries. Care delivery is inherently dependent on collaboration between multiple departments. This study aimed to present baseline data of pediatric neuro‐oncology care in Western Kenya and illustrate barriers and ...
Jesse Lemmen, Njie Albertine, Miyaada Abdi, Nilesh Mohan, Kibet Keitany, Marie Eliasson‐Hofvander, Gertjan Kaspers, Festus Njuguna   +7 more
wiley   +1 more source

The mutual interactions among Helicobacter pylori, chronic gastritis, and the gut microbiota: a population-based study in Jinjiang, Fujian. [PDF]

Front Microbiol
Li H, Hu Y, Huang Y, Ding S, Zhu L, Li X, Lan M, Huang W, Lin X.   +8 more
europepmc   +1 more source

Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active Comparator Study

Journal of Diabetes, Volume 17, Issue 4, April 2025.
ABSTRACT Background Dulaglutide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has been approved for improving glycemic control and reducing the risk of cardiovascular (CV) adverse events. A previous result in healthy Chinese male subjects demonstrated the pharmacokinetic (PK) similarity of LY05008 and the licensed product dulaglutide, with ...
Li Liu, Zhifeng Cheng, Lianwei Wang, Lili Zhang, Shunbin Li, Shu Li, Shuguang Pang, Qifu Li, Fang Bian, Junling Gu, Jie Shen, Liujun Fu, Baiping Sun, Yanyan Zhao, Changlin Dou, Zhaoyang Zeng, Lixin Guo   +16 more
wiley   +1 more source

Expression of growth hormone and its receptor in chronic atrophic gastritis and its clinical significance

, 2004
Jianmin Si
openalex   +1 more source

Meta‐Analysis: Inverse Association Between Helicobacter pylori Infection and Eosinophilic Oesophagitis

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 7, Page 1096-1109, April 2025.
In a large systematic review and meta‐analysis, exposure to Helicobacter pylori was significantly associated with decreased odds (46%) of eosinophilic oesophagitis and oesophageal eosinophilia. ABSTRACT Background Exposure to Helicobacter pylori (H. pylori) has been associated with a decreased risk of eosinophilic oesophagitis (EoE).
Irene Spinelli, Serena Porcari, Chiara Esposito, William Fusco, Francesca Romana Ponziani, Cristiano Caruso, Edoardo Vincenzo Savarino, Antonio Gasbarrini, Giovanni Cammarota, Marcello Maida, Antonio Facciorusso, Gianluca Ianiro   +11 more
wiley   +1 more source

How I treat iron‐refractory iron deficiency anaemia—An expert opinion‐based treatment guidance for children and adults

British Journal of Haematology, Volume 206, Issue 4, Page 1067-1076, April 2025.
In iron‐refractory iron deficiency anaemia, inappropriately elevated hepcidin levels impair enteral iron absorption and iron release from macrophages by interacting with ferroportin. Oral iron supplements (containing ~30 mg Fe2+ per 100 mg) are generally ineffective due to this hepcidin–ferroportin interaction although, in some cases, this can be ...
V. Hoving, A. E. Donker, S. E. M. Schols, D. W. Swinkels   +3 more
wiley   +1 more source

Helicobacter pyloriL-form and patients with chronic gastritis

, 2004
Ke-xia Wang, Lin Chen
openalex   +1 more source

Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India

Diabetes, Obesity and Metabolism, Volume 27, Issue 4, Page 2193-2205, April 2025.
Abstract Aim To evaluate the efficacy and safety of a triple fixed‐dose combination (FDC) therapy of dapagliflozin + glimepiride + metformin hydrochloride extended‐release (DAPA + GLIM + MET ER) tablets in Indian patients with type 2 diabetes mellitus (T2DM) inadequately controlled by combination of GLIM + MET.
Rakesh Sahay, Dinesh Gangwani, Manish Singh, Sandeep Gupta, Narendra Kale, Manoj Srivastava, Prakash Kurmi, Jayesh Ambaliya, Nilesh Lomte, Sandip Gofne, Saurabh Agarwal, Priyanka Kashid, Vikas Agarwal, Pradeep Rai, Surendra Sharma, L. Sreenivasa Murthy, Mandodari Rajurkar, Shruti Saha, Piyush Patel, Dipak Patil, Pravin Ghadge, Lalit Lakhwani, Suyog Mehta, Sadhna J. Joglekar   +23 more
wiley   +1 more source